EcoDrugPlus

Prostaglandin E Receptor 1b (Subtype Ep1)

Ensembl ID : ENSEEEG00000018787
Gene Symbol: PTGER1B
4 Cross references
163 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSEEEG00000012800
Gene Symbol: PTGER2A
4 Cross references
203 Possible Orthologues:

Prostaglandin E Receptor 2b (Subtype Ep2)

Ensembl ID : ENSEEEG00000011052
Gene Symbol: PTGER2B
1 Cross references
172 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSEEEG00000005259
Gene Symbol: PTGER3
4 Cross references
197 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) A

Ensembl ID : ENSEEEG00000010029
Gene Symbol: PTGER4A
4 Cross references
202 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSEEEG00000014183
Gene Symbol: PTGER4B
4 Cross references
202 Possible Orthologues:

Prostaglandin F Receptor (Fp)

Ensembl ID : ENSEEEG00000004721
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSEEEG00000020570
Gene Symbol: PTGIR
4 Cross references
188 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSEEEG00000000418
Gene Symbol: PTGS1
4 Cross references
196 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2a

Ensembl ID : ENSEEEG00000019298
Gene Symbol: PTGS2A
4 Cross references
165 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2b

Ensembl ID : ENSEEEG00000012682
Gene Symbol: PTGS2B
4 Cross references
213 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSEEEG00000001825
Gene Symbol: PSMA1
4 Cross references
271 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).